Physician profile
Aaron Jaffe
NPI 1922457894
$2,760.04
in general payments reported to CMS, 2019-2025
15 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $372 · 2021: $525 · 2022: $133 · 2023: $44.83 · 2024: $1,075 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,052 · Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,052.25 |
| Food and Beverage | $258.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,112.25 | 2024-2025 | |
| Glaxosmithkline, LLC. | $467.91 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $402.22 | 2020-2025 | Fasenra, Tezspire |
| Novo Nordisk INC | $125.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.92 | 2020 | |
| Genentech USA, INC. | $99.99 | 2019 | |
| Edwards Lifesciences Corporation | $95.79 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $80.79 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.60 | 2022 | |
| Electromed, INC. | $51.39 | 2022-2025 | Smartvest |
| Advanced Respiratory, INC | $33.89 | 2020 | |
| Dexcom, INC. | $33.31 | 2025 | Dexcom G6 Transmitter |
| Cormedix INC. | $22.72 | 2024 | Defencath |
| Insmed, INC. | $19.82 | 2021 | |
| Amgen INC. | $16.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.